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Abstract Control of human tuberculosis (TB) requires induction and maintenance of both
macrophage and T cell effector functions. We demonstrate that pulmonary TB patients with a vitamin
D deficiency had significantly reduced local levels of the vitamin D-inducible antimicrobial peptide LL-37
in granulomatous lesions compared to distal parenchyma from the infected lung. Instead, TB lesions
were abundant in CD3+ T cells and FoxP3+ regulatory T cells as well as IgG-secreting CD20+ B cells,
particularly in sputum-smear positive patients with cavitary TB. Mycobacteria-specific serum IgG titers
were also elevated in patients with active TB. An up-regulation of the B cell stimulatory cytokine IL-21
correlated withmRNA expression of CD20, total IgG and also IL-10 in the TB lesions. Altogether, vitamin
D-deficient TB patients expressed a weak antimicrobial response but an IL-21 associated expansion of
IgG-secreting B cells combined with a rise in FoxP3+ regulatory T cells at the local site of infection.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).terleukin; IFN, interferon;
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86 S. Rahman et al.1. Introduction
Tuberculosis (TB) remains a major global health problem and
thus an improved understanding of the pathogenic mecha-
nisms involved in the progression of infection and disease is
required to develop new therapeutic strategies. Protective
host immunity in Mycobacterium tuberculosis (Mtb) infec-
tion is dependent on both innate [1] and adaptive [2]
immune responses. This includes important antimicrobial
responses of both activated macrophages and T cells to
produce potent bactericidal compounds such as reactive
oxygen and nitrogen intermediates, antimicrobial peptides
and granule-associated cytolytic effector molecules, respec-
tively [3,4]. Macrophages kill intracellular Mtb bacilli primarily
through production of nitric oxide (NO) [5] as well as the
cationic antimicrobial peptide human cathelicidin, LL-37 [6].
The importance of LL-37 in human TB has been revealed partly
through studies on the immunomodulatory effects of vitamin
D, which is known to promote LL-37 expression and intracel-
lular killing of Mtb [7,8]. Importantly, low levels of vitamin
D have been shown to be associated with an enhanced
susceptibility to develop active TB [7]. LL-37 disrupts bacterial
membrane integrity and also induces autophagy, which is a
physiological process known to enhance intracellular degra-
dation of mycobacteria [9]. Cytolytic T cells (CTLs) are also
important in TB immune control and execute killing of
Mtb-infected cells by the coordinated release of the pore-
forming protein perforin and the antimicrobial peptide
granulysin [10,11]. We have previously demonstrated defec-
tive expression of perforin and granulysin in CD8+ CTLs at the
site of Mtb infection in lung [12] and lymph nodes [13] from
patients with progressive TB. Impaired CTL responses may be
the consequence of excess regulatory T cell (Treg) responses
including local expansion and infiltration of FoxP3+ Treg cells
[13,14] that have been reported to suppress immune
responses in TB [14,15]. Although Treg cells could reduce
local immunopathology in chronic infections such as TB, a high
abundance of Treg cells could also prevent protective Th1
responses and result in a failure to control the infection [16].
Whereas protective immunity in human TB requires proper
infiltration and activation of CD4+ Th1 cells and CD8+ CTLs [3,4],
the need for B cells and humoral immune responses remains
controversial [17]. Since Mtb is an intracellular pathogen,
antibody-mediated immune responses may not confer efficient
protection. Instead, Mtb-specific antibody responses may be
useful for diagnostic purposes or as biomarkers of active disease
and/or progression of disease [18,19]. However, B cells can also
act as antigen-presenting cells that may have a role to enhance
activation of local T cell responses in Mtb-infected tissues
[17]. Recently, it has become evident that a subset of
regulatory B cells (Breg cells) control inflammation and
autoimmunity in both mice [20] and humans [21]. There may
also be a functional link between certain rare subsets of Breg
cell and Treg cells that may contribute to the immunological
balance in different human diseases [22].
A variety of inflammatory and immunoregulatory cyto-
kines are produced during active TB infection that could
influence the outcome of disease at the local site of
infection. Typically, Th1 (IFN-γ, TNF-α) and Th17 (IL-17)
cytokines promote bactericidal functions in macrophages
and T cells and also regulate granuloma formation in TB,
while Th2 cytokines (IL-4, IL-13) and anti-inflammatorycytokines (IL-10, TGF-β) counteract Th1 responses and
promote humoral responses [4,23]. While IL-17 has been
shown to regulate the production of antimicrobial peptides
[24] as well as the activation of IFN-γ expressing T cells at
mucosal sites [25], the potential role of IL-21 in mycobac-
terial infections has been less investigated. Interestingly,
IL-21 has been found to be highly potent to promote
activation and differentiation of human B cells [26] including
antibody-secretion and Ig-class switch [27].
In this study, we aimed to discover the nature of the
unfavorable immune responses present at the local site of
infection in patients with chronic pulmonary TB. For the first
time we demonstrate that active TB patients with low serum
levels of vitamin D had significantly reduced expression of LL-37
in pulmonary lesions where mycobacterial antigens were
accumulated. Instead, lymphoid aggregates consisting of both
CD3+ T and FoxP3+ T cells as well as CD20+ B cells and
IgG-secreting cells were significantly increased in the TB lesions
compared to distal lung parenchyma of the Mtb-infected lungs.
We also detected elevated mycobacteria-specific IgG titers in
serum samples from active TB patients compared to healthy
controls. Interestingly, we found a significant up-regulation of
IL-21 as well as IL-10 in the granulomatous TB lesions, which
may promote humoral and regulatory immune responses at
the local site of Mtb infection. The findings from this study
may be used to describe novel immune response profiles
that are associated with progression of active TB disease in
humans.2. Materials and methods
2.1. Patients
Lung tissue biopsies were obtained from patients with active
pulmonary TB (n = 19) who underwent surgical treatment
for chronic TB at the Department of Thoracic Surgery at
St Petersburg State City TB Hospital, Russia, as previously
described [12]. Inclusion criteria: HIV-negative patients
N18 years with a TB diagnosis based on TB contact and
clinical symptoms (severe weight loss, N8 weeks of produc-
tive cough and hemoptysis), typical chest x-ray findings,
positive sputum-smear microscopy (11/19), positive Mtb
culture of lung tissue homogenate (6/19), histopathology
consistent with TB (19/19) and/or a positive PCR (19/19).
Despite extensive chemotherapy including ≥5 first- and
second-line drugs for more than 6 months, patients with a
confirmed TB diagnosis failed to respond to conventional
treatment and thus surgical treatment was performed on all
study subjects to limit mycobacterial load and disease
progression. From the resected lung segments, tissue
biopsies were collected from the granulomatous TB lesion
(pathological site) and also from a distal, macroscopically
normal area of the lung parenchyma (unaffected site). Thus,
we compared paired observations obtained from different
sites of the Mtb-infected lung of the same individual. The
discrimination between pathological TB lesion and macro-
scopically normal lung parenchyma was made by the surgeon
and a TB specialist based on visual examination of the
resected lung segments. Tissue biopsies were immediately
frozen and stored at −85 °C for immunological analysis.
Blood samples were also collected from the patients at the
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at −85 °C for molecular analysis. Serum samples were also
obtained from n = 10 Swedish healthy controls recruited at
the Karolinska University Hospital Huddinge. Patients were
recruited into the study after informed consent and ethical
approval in both Russia and Sweden.
2.2. Quantitative real-time PCR of lung
tissue sections
Cryopreserved lung tissues were embedded in OCT-compound
(Tissue-TEK, Sakura, Alphen aan den rijn, theNetherlands) and
sectioned in 2×50 μm thick sections that were used for RNA
extraction (Ambion RiboPure extraction kit, Invitrogen,
Carlsbad, CA). Reverse transcription of RNA was per-
formed using a high capacity cDNA reverse transcription
kit (Applied Biosystems, Foster City, CA). Amplification of
18S, CD68, CD3, CD20, FoxP3, iNOS, LL-37, granzyme A,
perforin, granulysin, total IgG, TNF-α, IFN-γ, IL-17A, IL-21,
IL-4, IL-13, IL-10 and TGF-β cDNA was performed using the ABI
PRISM 7700 sequence detection system and commercial
6-carboxyfluorescein dye-labeled TaqMan MGB probes and
primers (Applied Biosystems). Cycle threshold (Ct) values for
the target genes were normalized to the Ct value for the
housekeeping gene 18S. The relative expression of the target
genes was calculated by comparing the Ct value for the TB
lesion to that for the distal lung tissue from the same patient
[28]. Data are presented as fold change of mRNA in the TB
lesions compared to the mRNA expression in the distal lung
parenchyma.
2.3. Immunohistochemistry and in situ computerized
image analysis of lung tissue sections
Immunohistology and in situ computerized image analysis
were used to study tissue morphology and cellular pheno-
types and to quantify the functional expression of effector
molecules in TB infected tissues. OCT-embedded lung tissues
were sectioned in 8 μm thick sections and mounted on HTC
microscope slides (Histolabs, Gothenburg, Sweden) and
fixed in 4% formaldehyde (Sigma, Stockholm, Sweden) for
15 minutes. Immunohistochemistry was performed accord-
ing to the ABC-method [12]. Primary antibodies were CD68,
MAC387, CD3 (BD, San Diego, CA), neutrophil elastase,
polyclonal Mycobacterium bovis bacille Calmette-Guérin
(pAb-BCG) (Dako, Glostrup, Denmark), CD20 and FoxP3 (Abcam,
Cambridge, UK), IgG and IL-21 (Jackson ImmunoResearch
Laboratories, West grove, PA), IL-10 (Nordic Biosite, Stockholm,
Sweden) as well as iNOS (BD/Transduction Laboratories, San
Jose, CA). LL-37 was kindly provided by Dr. Andreas Cederlund
at the Department of Medical Biochemistry and Biophysics
(MBB) at Karolinska Institutet. Biotinylated secondary antibod-
ies included goat anti-mouse IgG, rabbit anti-goat IgG and swine
anti-rabbit F(ab´)2 from Dako. Tissue sections stained with
secondary antibodies only were used as negative controls.
Positive immunostaining (brown) was developed using a
diaminobenzidine substrate (Vector Laboratories, Burlingame,
CA) and hematoxylin was used for nuclear counterstaining
(blue). Immunohistochemical stainings were analysed by ac-
quired computerized image analysis (ACIA) using a DMR-X
microscope and a digital computerized Quantimet 5501 Wimage analyser (Leica Microsystems, Wetzlar, Germany) [29].
Single-cell protein expression was assessed in 20 to 50
high-power fields using a Qwin 550 software program (Leica
Imaging Systems, Germany). Protein expression was deter-
mined in the total relevant cell area (fibrotic and necrotic
tissue areas were excluded) where the total cell area was
defined as the nucleated and cytoplasmic area within the
tissue biopsy. Data are presented as ACIA values, calculated as
the percentage of the positively stained area in the cell area
multiplied by the total mean intensity of positive staining.
Tissues included in the software analysis had a mean size of
5.0×106 μm2. Two-color staining was performed using indirect
immunofluorescence and analysis performed using a Nikon
A1R spectral detector confocal microscope (Nikon Instru-
ments, Amstrelveen, Netherlands). For dual staining, tissues
were stainedwithmouse anti-humanCD138 and CD20 (Abcam)
or rabbit anti-human IgG (Jackson ImmunoResearch Labora-
tories) followed by the appropriate Alexa Fluor-conjugated
secondary antibodies (Molecular Probes, Eugene, Oregon).
2.4. BCG-specific IgG ELISA
The release of mycobacteria-specific IgG antibodies in serum
samples obtained from the study subjects was quantified using
a Bacillus Calmette Guerin (BCG)-specific ELISA [18]. Briefly, a
BCG vaccine (Japan BCG Laboratories, Tokyo, Japan) was used
to coat Maxisorb plates (Nunc, Roskilde, Denmark) overnight at
4 °C. The plates were washed with PBS–0.05%Tween-20
(Sigma) and blocked with PBS + 10%FCS. Serum samples from
patients and controls were added (100 μl/well, diluted 1:1800)
and incubated for 2 h at 37 °C before washing and addition
of a rabbit anti-human IgG horseradish peroxidase conju-
gate (Jackson ImmunoResearch Laboratories) for 2 h at
room temperature. Dilution buffer (PBS + 10%FCS) was used
as negative control. The enzyme-substrate reaction was
developed after 20 minutes using O-phenylenediamine
(OPD) (Sigma) substrate solution. BCG-specific IgG titers
were expressed as optical density (OD) measured at 492 nm
multiplied by the dilution factor.
2.5. Vitamin D levels in serum samples
Concentrations of 25-hydroxyvitamin D2 and D3 in serum
samples obtained from the study subjects were measured
using the DiaSorin assay performed at the Chemical
Laboratory, Karolinska University Hospital Solna. Serum
samples were collected from TB patients and uninfected
controls during the first six calendar months of the year
(January-July).
2.6. Statistical analysis
Data that passed a normal distribution test (D´Agostino and
Pearson omnibus normality test) were analyzed using a
parametric test. Statistical significance of differences in
serum vitamin D levels in sputum-smear positive (n = 11) and
sputum-smear negative (n = 8) TB patients compared to
controls (n = 10) was determined by a non-parametric
Kruskal-Wallis test. Fold changes of mRNA determined as
the ratio of mRNA expression in the TB lesions compared to
distal lung parenchyma (n = 19) were analyzed using a
Table 1 Demographics of pulmonary TB patients a.
Chest X-ray findings b Number Gender
(M/F) c
Age (yr)
(mean)
Sputum
positive a
Culture
positive a
PCR
positive a
Histology
positive a
Cavitary TB 10 6/4 31 8 5 10 10
Non-cavitary TB 9 8/1 46 3 1 9 9
a All patients had clinical symptoms of active pulmonary TB at the time of surgery despite prior treatment with ≥5 first- and second-line
anti-TB drugs. TB diagnosis was based on clinical history, sputum-smear microscopy, Mtb culture of tissue homogenate, PCR,
histopathology of tissue sections and chest X-ray data.
b The clinical forms of pulmonary TB were diagnosed using chest X-ray as either cavitary TB (formed cavern N3 cm, with a fibrotic capsule) or
non-cavitary TB (pulmonary infiltrates or multiple nodular densities with various forms and sizes). Cavitary TB was considered to include
extensive tissue destruction with formation of a fibrotic cavern whereas non-cavitary TB included limited fibrotic processes.
c M, male; F, female.
88 S. Rahman et al.paired t test and the data are presented as a box and whisker
plot (median and range). ACIA values in the TB lesions
compared to distal lung parenchyma (n = 19) were analyzed
using a paired t test and the data are presented in bar graphs
(mean +/− SE). Values from two individual experiments
are shown. ACIA values determined in the TB lesions from
sputum-smear positive (n = 11) compared to sputum-
smear negative (n = 8) TB patients was analyzed using a
non-parametric Mann–Whitney test and the data are present-
ed in bar graphs (median +/− IQR). Spearman’s correlation
test was used for the correlation analyses. Differences
between groups were considered to be statistically significant
at p b 0.05. The statistical analyses were performed in
GraphPad Prism-5.
3. Results
3.1. Decreased serum levels of vitamin D is associated
with low expression of LL-37 in TB lesions that have a
high content of mycobacterial antigens
In this study, lung tissue biopsies and serum samples were
collected from 19 patients with cavitary or non-cavitary
forms of chronic pulmonary TB (Table 1) [12]. First, we
assessed serum levels of 25-hydroxyvitamin D in samples
obtained from the TB patients and healthy controls (n = 10).
Vitamin D is an immunomodulatory molecule that regulates
both innate and adaptive immune responses and low levels of
vitamin D have been shown to be associated with an enhancedFigure 1 Pulmonary TB patients with a vitamin D deficiency ex
peptide LL-37 in granulomatous lesions from the Mtb-infected lun
positive (sputum-pos; n = 11) and sputum-smear negative (sputum-ne
10). The dotted lines mark the threshold for vitamin D deficienc
Representative immunohistochemical images demonstrate expressio
lesions (magnification ×25) and (C) BCG antigens and LL-37-express
computerized image analysis was used to determine the expression (m
to distal lung (n = 19). (D) Relative mRNA expression (median and ran
lung parenchyma (n = 19) was quantified using real-time PCR.
Immunohistochemical images illustrates CD68+ macrophages and iNO
while in situ imaging was used to determine the expression (mean ±
(n = 19). Arrows in the images indicate positive cells (brown) where
p b 0.05 *, p b 0.01 **, p b 0.001 ***.susceptibility to develop active TB [7]. Accordingly, we found
that all TB patients were vitamin D deficient (b25 nmol/l), and
both sputum-positive and sputum-negative patients expressed
vitamin D levels that were significantly lower compared to the
control cohort (p b 0.001 and p b 0.01, respectively) (Fig. 1A).
Next, we assessed local immune responses including distribu-
tion and functional expression of myeloid cells and lymphocyte
subsets in cryopreserved tissue sections from the Mtb-infected
lungs using quantitative mRNA and in situ computerized image
analysis. Microscopic examination of gross TB lesions at a
lower magnification revealed large necrotic granulomas, with
CD3+ T cells in the mantel area and neutrophils in the core
region (Fig. 1B). Immunostaining using a polyclonal M. bovis
BCG antibody with documented cross-reactivity to Mtb-
antigens [30], revealed a significantly (p b 0.01) higher
antigen expression in pulmonary TB lesions compared to the
distal lung parenchyma (Fig. 1C), which suggest persistence of
mycobacteria primarily at the local site of infection. Contrary,
significantly (p b 0.0001) lower levels of the antimicrobial
peptide LL-37were detected in the TB lesions compared to the
distal sites (Fig. 1B), which may suggest a specific down-
regulation of LL-37 at the site of mycobacterial infection.
Quantitative real-time PCR demonstrated that mRNA levels of
innate immune cells and effector molecules including markers
of macrophages (CD68), inducible nitric oxide synthase (iNOS/
NOS2) and LL-37, were all expressed at similar levels in the TB
lesions compared to distal lung parenchyma (Fig. 1D). Despite
comparable mRNA levels of CD68, in situ image analysis
revealed that protein expression of CD68 was significantly
(p = 0.003) lower in the TB lesions compared to the distalpress low local levels of the vitamin D-inducible antimicrobial
g. (A) S-vitamin D levels (median and range) in sputum-smear
g; n = 8) TB patients compared to healthy Swedish controls (n =
y (b25 nmol/l) and insufficiency (25–75 nmol/l), respectively.
n of (B) CD3+ T cells and neutrophil elastase in granulomatous TB
ing cells in the Mtb-infected lung (magnification ×125). In situ
ean ± SE) of BCG antigens and LL-37 in the TB lesions compared
ge) of CD68, iNOS and LL-37 in the TB lesions compared to distal
The dotted line represents a relative difference of 1. (E)
S-expressing cells in the Mtb-infected lung (magnification ×125)
SE) of CD68 and iNOS in the TB lesions compared to distal lung
as negative cells (blue) were counterstained with hematoxylin.
89Impaired local immunity in vitamin D-deficient TB patientssites (Fig. 1E). In addition, MAC387, which is a protein found
on monocytes, reactive macrophages, neutrophils and muco-
sal epithelia, were also significantly (p = 0.01) lower in the TB
lesions (data not shown); while iNOS expression was similar in
the TB lesions and distal lung parenchyma (Fig. 1E).A.
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90 S. Rahman et al.elevated levels of CD3+ T cells at this site [12,13].
Accordingly, mRNA expression of CD3 and the granule-
associated effector molecule granzyme A were significantly
(p = 0.03 and p = 0.008, respectively) higher in TB lung
lesions compared to distal lung parenchyma, while the
relative expression of perforin and granulysin were similar at
the two sites (Fig. 2A). Instead, mRNA expression of the Treg
marker FoxP3 was significantly (p b 0.0001) increased in the
TB lesions (Fig. 2A). In situ image analysis demonstrated that
the T cells were mostly organized in inflammatory infiltrates
or lymphoid aggregates (LA) in the granulomatous TB lesions,
while no such structures were observed in the distal lung
parenchyma (Fig. 2B). Corresponding to mRNA data, ac-
quired computerized image analysis revealed significantly
(p b 0.0001) elevated levels of both CD3+ T cells and FoxP3+
Treg cells in the TB lesions as compared to the distal sites
(Fig. 2B).A.
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Here, we found a significant (p b 0.0001) induction of both
CD20 and total IgG mRNA at the TB lesion site (Fig. 3A).
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92 S. Rahman et al.induction of antibody responses in the circulation of the TB
patients and found that BCG-specific IgG titers were signifi-
cantly higher in both sputum-smear positive (p b 0.001) and
sputum-smear negative (p b 0.05) TB patients compared to
healthy controls (Fig. 3D).A.
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This study was performed to explore the nature of the
unfavorable immune responses present at the local site of
Mtb infection in the lung of patients with a chronic incurable
TB disease. For the first time we demonstrate that
pulmonary TB patients with a vitamin D deficiency expressed
low local levels of the vitamin D-inducible antimicrobial
peptide LL-37 in TB lesions from the Mtb-infected lung.
While mycobacterial antigens were accumulated in the TB
lesions, CD68+ and MAC387+ innate immune cells were reduced
compared to distal lung parenchyma although the expression of
iNOS was similar in the lesion and distal sites. Impaired
expression of LL-37 as well as granulysin in pulmonary TB
lesions, may suggest a selective down-regulation of antimicro-
bial peptides at the site of bacterial persistence. Instead,
lymphoid aggregates in the granulomatous TB lesions were
enriched with CD3+ T cells and FoxP3+ Treg as well as CD20+ B
cells and IgG-secreting cells. In addition, we found elevated
levels of mycobacteria-specific IgG titers in serum samples
from active TB patients compared to healthy controls. While
we have previously found an impairment of perforin and
granulysin expression in local CD8+ CTLs in the Mtb-infected
lung [12], elevated levels of FoxP3+ Treg cells in the TB lesions
may suggest that the ratio of effector T cells to Treg cells are
significantly decreased at the Mtb-infected site. Moreover, TB
lesions contained high levels of the B cell stimulatory cytokine
IL-21 that correlated to mRNA expression of both CD20 and
total IgG levels in the tissue. In comparison to sputum-negative
patients with non-cavitary TB, sputum-smear positive TB
patients who mostly suffered from cavitary TB, expressed
relatively lower levels of LL-37 in the TB lesions, whereas
FoxP3+ Treg cells and IgG secreting B cells were highly
abundant at this site. Collectively, these results may suggest
that impaired antimicrobial effector cell responses may be
associated with an IL-21 driven expansion or infiltration of
IgG-secreting B cells and a concomitant rise in FoxP3+ Treg cells
at the local site of Mtb infection that may contribute to a
persistent TB infection.
In chronic infections such as TB, it is of significant
relevance to study host-pathogen interactions in the
infected tissue, since immune cells are recruited to and
accumulate at the local site of bacterial replication [23].
Here, granuloma formation including organized clusters of
macrophages and lymphocytes in Mtb-infected tissue is a
typical feature of human TB disease [13,23,30,31]. We
observed a lower expression of macrophages in the TB
lesions compared to the distal sites, which suggests that Mtb
infection results in a depletion of infected host cells at the
site of infection, especially in patients with advanced TB
disease. Accordingly, the cellularity of necrotic granulomas
in the lesions was lower compared to non-necrotic granulo-
mas. The presence of lymphoid aggregates in close proximity
to TB granulomas have been described both in mice [32,33]
and human pulmonary tissue [30,31], which indicates that
such secondary lymphoid structures play a role in the control
of local host-pathogen interactions. We previously demon-
strated that FoxP3+ Treg cells and TGF-β are enriched in
human lymph node granulomas [13]. Similarly, the walls of
cavitary TB lesions from human lungs have also been shown
to contain particularly high numbers of FoxP3+ Treg cells
that may contribute to the inability of the immune system toeradicate TB [34]. The presence of CD4+ FoxP3+ Treg cells
[35] as well as CD20+ B cells and antibodies [36] was recently
demonstrated in the granulomas of Mtb-infected non-human
primates, which support the notion that these cell subsets
may modulate the host-pathogen interactions at the local
site of infection.
Our findings suggest that loss of cellular immune control
is related to an enhanced activation of humoral immune
responses in human TB. Several studies suggest that B cells
and antibodies are required to control mycobacterial
infections [32,37,38], while other studies fail to show any
protective effects of B cells [39,40]. Possibly, B cell
responses may play a role in early protection and the
induction of adaptive immunity in TB [40,41]; however, in
the chronic phase of TB infection, enhanced antibody-
responses may instead be a consequence of exacerbated
disease. Humoral immunity is driven by soluble Mtb-antigens
that are released and spread from destructive lesions
present at the site of Mtb infection, especially in patients
with extensive pulmonary TB including cavitary TB [42].
Accordingly, high levels of total and Mtb-specific serum
antibodies have previously been shown in patients with
advanced TB disease [43,44]. In addition, we recently
demonstrated that elevated levels of mycobacteria-specific
IgG-secreting cells in the peripheral circulation of patients
with active TB, were associated with reduced Mtb-specific
IFN-γ production and more severe forms of TB disease [18].
Similar to TB, Mycobacterium leprae-specific serum IgG1
antibodies in patients with leprosy show a direct correlation
with bacterial load [45]. Importantly, antibody responses
and antibody-secreting CD138+ plasma B cells are also
elevated at the site of M. leprae infection in skin lesions
from patients with advanced disseminated forms of disease
[46], which suggest that humoral immunity in mycobacterial
infections may not be associated with protection but rather
to disease progression.
B cells are pleiotropic cells that can mediate multiple
functions including antigen presentation, antibody pro-
duction but also regulatory functions. Here, it was recently
demonstrated that CD19+CD24hiCD38hi Breg cells isolated from
peripheral blood of healthy individuals, have the ability to
suppress T cell functions including the differentiation of IFN-γ
and TNF-α producing Th1 cells but also IL-17 producing Th17
cells [47,48]. Breg cells have also been shown to suppress the
production of TNF-α by macrophages [21], while the effect on
other macrophage functions such as the expression of LL-37 is
currently unknown. Interestingly, immune suppression
mediated by Breg cells seems to be primarily dependent on
IL-10 [20,21,47,48]. Importantly, CD19+CD24hiCD38hi Breg
cells promote the expansion of FoxP3+ Treg cells with
suppressive functions while Breg cells from patients with
autoimmune diseases such as systemic lupus erythemato-
sus (SLE) [47] or rheumatoid arthritis (RA) [48] fail to
sustain their suppressive capacity and to maintain FoxP3+
Treg cells. RA patients with active disease also had
reduced numbers of CD19+CD24hiCD38hi B cells in periph-
eral blood compared to control groups [48]. In this regard,
we recently demonstrated that the proportion of circu-
lating CD19+CD27hiCD38hi plasmablasts expressing
cell-surface IgG was significantly higher in peripheral blood
from patients with active TB compared with asymptomatic
and healthy controls [18]. TB patients have also been found
95Impaired local immunity in vitamin D-deficient TB patientsto have elevated levels of a functionally suppressive
CD19+CD1d+CD5+ B cell subset in peripheral blood [49].
Likewise, Breg cells could promote pulmonary infiltration of
FoxP3+ Treg cells that prevent allergic inflammation in
worm-infected mice [50]. Thus, while reduced numbers of
Breg cells may fail to limit inflammatory responses in patients
with autoimmune diseases, excess numbers of Breg cells may
prevent imperative antimicrobial effector responses in human
infectious diseases such as TB, partly by local expansion of
FoxP3+ Treg cells.
Our present findings revealed that the B cell stimulatory
cytokine IL-21 was significantly elevated in the TB lesions
compared to the distal lung parenchyma. Recent research
supports the notion that IL-21 is the major T cell-derived
cytokine that drives differentiation of human plasma B cells
into antibody-secreting cells [51]. It has been determined
that IL-21 regulates the function and persistence of germinal
center B cells [52] and is a potent inducer of IgG-secreting
plasma cells [26]. Accordingly, IL-21R-deficient mice exhib-
ited a severe defect in IgG1 production following antigen
priming [53], demonstrating the importance of IL-21 in
plasma B cell differentiation. Interestingly, it was recently
shown that in vivo development of functional IL-10-
producing Breg cells are dependent on the production of
IL-21 [54]. Thus, although IL-10 could potentially be
produced by a number of cell types including T and B cells
as well as macrophages, it is tempting to speculate that
IL-10 is primarily produced by Breg cells present in local TB
lung lesions. Moreover, increased levels of IL-21 have been
shown to facilitate Treg-mediated inhibition of perforin
expression in T cells and to enhance viral replication in the
spleen of Coxsackievirus infected mice [55]. Further in vivo
and in vitro experiments are required to investigate the
specific role of IL-21 in the regulation of immune responses
in TB.5. Conclusions
In summary, our findings suggest that the progression of
active pulmonary TB is associated with vitamin D deficiency
and low local levels of LL-37 as well as a concomitant
enrichment of FoxP3+ Treg cells and IgG-secreting CD20+ B
cells in the granulomatous TB lesions. Elevated levels of
FoxP3+ Treg cells may alter the immunological balance and
inhibit crucial antimicrobial effector cell responses including
local production of LL-37 and granulysin in the Mtb-infected
lung. In addition, IL-21 may promote the accumulation of
IgG-secreting B cells, which could be the consequence of an
impaired cellular immune response that contributes to the
persistence of TB infection. Future studies determining the
functional link between different B cells subsets and local
Treg cells in human TB, would therefore be helpful.Financial support
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